BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHIL
2601
DELISTED
Diamond Hill
DHIL
| $48.8M | ﹤0.01% |
260,670
-9,084
| -3% | -$1.69M |
|
2602
eHealth
EHTH
$45.1M
| $48.8M | ﹤0.01% |
3,933,180
-21,598
| -0.5% | -$372K |
|
|
BRY
2603
DELISTED
Berry Corp
BRY
| $48.8M | ﹤0.01% |
4,727,569
-151,863
| -3% | -$1.44M |
|
2604
Banco Santander Chile
BSAC
$16.4B
| $48.7M | ﹤0.01% |
2,155,899
-1,471,233
| -41% | -$29.4M |
|
2605
GSK
GSK
$103B
| $48.7M | ﹤0.01% |
894,105
-6,496
| -0.7% | -$353K |
|
2606
CALL
Alcoa
AA
$12.4B
| $48.6M | ﹤0.01% |
540,300
-1,606,400
| -75% | -$117M |
|
|
HAAC
2607
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $48.4M | ﹤0.01% |
4,914,296
| – | – |
|
2608
Ryanair
RYAAY
$31.2B
| $48.3M | ﹤0.01% |
1,386,780
-820,295
| -37% | -$33.7M |
|
|
EGIO
2609
DELISTED
Edgio, Inc. Common Stock
EGIO
| $48.2M | ﹤0.01% |
231,030
-1,866
| -0.8% | -$311K |
|
|
ELP
2610
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $48.2M | ﹤0.01% |
7,700,364
+66,684
| +0.9% | +$349K |
|
2611
UBS Group
UBS
$175B
| $48.2M | ﹤0.01% |
2,465,156
+142,328
| +6% | +$2.69M |
|
2612
Alignment Healthcare
ALHC
$2.8B
| $48.2M | ﹤0.01% |
4,288,997
-236,990
| -5% | -$2.13M |
|
|
SP
2613
DELISTED
SP Plus Corporation
SP
| $48.2M | ﹤0.01% |
1,535,721
-17,532
| -1% | -$508K |
|
|
KZR
2614
DELISTED
Kezar Life Sciences
KZR
| $48.1M | ﹤0.01% |
289,707
+21,005
| +8% | +$3.01M |
|
2615
Recursion Pharmaceuticals
RXRX
$1.76B
| $48M | ﹤0.01% |
6,707,757
-54,927
| -0.8% | -$584K |
|
2616
Bionano Genomics
BNGO
$12.9M
| $48M | ﹤0.01% |
30,993
-107
| -0.3% | -$144K |
|
2617
Great Southern Bancorp
GSBC
$893M
| $47.8M | ﹤0.01% |
810,622
-15,700
| -2% | -$946K |
|
2618
Atea Pharmaceuticals
AVIR
$376M
| $47.8M | ﹤0.01% |
6,624,693
+843,496
| +15% | +$5.73M |
|
2619
Mercantile Bank Corp
MBWM
$1.07B
| $47.8M | ﹤0.01% |
1,349,943
-22,697
| -2% | -$848K |
|
|
ELAT
2620
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $47.8M | ﹤0.01% |
1,172,733
-56,884
| -5% | -$2.38M |
|
|
GOLD
2621
Gold.com Inc
GOLD
$1.24B
| $47.4M | ﹤0.01% |
1,224,842
-33,110
| -3% | -$1.13M |
|
2622
ARKO Corp
ARKO
$840M
| $47.3M | ﹤0.01% |
5,197,459
-1,670,583
| -24% | -$14.1M |
|
2623
SAP
SAP
$226B
| $47.1M | ﹤0.01% |
424,703
-27,844
| -6% | -$3.39M |
|
2624
Theravance Biopharma
TBPH
$875M
| $47.1M | ﹤0.01% |
4,929,140
-73,223
| -1% | -$718K |
|
2625
Ascendis Pharma A/S
ASND
$16B
| $47.1M | ﹤0.01% |
401,084
+80,988
| +25% | +$9.38M |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.